Chandan Healthca — 360° view

Chandan Healthca, a company in the Healthcare Service Provider industry, reported revenue of ₹58 crore and net profit of ₹18 crore for the September 2026 quarter.

Chandan Healthca (NSE: CHANDAN-SM) closed at ₹240.00 on 20 Nov 2026, down 27.8% over the past year. Its market capitalisation is ₹587 crore and it trades at 22.3 times earnings.

Share price
₹240.00 (20 Nov 2026)
Market cap
₹587 Cr (20 Nov 2026)
P/E
22.34 (20 Nov 2026)
Revenue
₹58 Cr (September 2026 quarter)
Net profit
₹18 Cr (September 2026 quarter)
ROCE
23.3% (FY26)
ROE
19.8% (FY26)
Book value
₹85.0 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹350.95 / ₹185.40 (20 Nov 2026)
1-year return
-27.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: CHANDAN-SM

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.